Manifestation of paroxysmal nocturnal hemoglobinuria after COVID-19 mRNA vaccination

Blood Cells Mol Dis. 2022 Mar:93:102641. doi: 10.1016/j.bcmd.2021.102641. Epub 2021 Dec 30.

Authors

Kawthar Jarrah¹, Layal Al Mahmasani¹, Ali Atoui¹, Rayan Bou-Fakhredin², Ali T Taher³

Affiliations

¹ Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
² Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
³ Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon. Electronic address: ataher@aub.edu.lb.

No abstract available

Keywords: COVID-19; Paroxysmal nocturnal hemoglobinuria; Vaccine; mRNA.

Publication types

Case Reports
Letter

MeSH terms

Adult
BNT162 Vaccine / adverse effects*
BNT162 Vaccine / therapeutic use
COVID-19 / immunology
COVID-19 / prevention & control*
Complement Activation
Female
Hemoglobinuria, Paroxysmal / diagnosis
Hemoglobinuria, Paroxysmal / etiology*
Hemoglobinuria, Paroxysmal / immunology
Hemolysis
Humans

Substances

BNT162 Vaccine